Trodelvy 180Mg Injection
Call for Price
Brand: Trodelvy
Generic: Sacituzumab Govitecan-hziy
Manufacturer: Pfizer
Drug class: antibody-drug conjugates (ADCs), specifically functioning as a Trop-2-directed antibody and topoisomerase inhibitor conjugate.
Description
Introduction to Trodelvy 180mg Injection
Trodelvy 180mg Injection contains sacituzumab govitecan-hziy. It is an anti-cancer medicine developed by Gilead Sciences and belongs to a group of medicines called antibody-drug conjugates (ADCs).
Trodelvy is used to treat certain types of advanced breast cancer and urothelial cancer in adults who have received previous cancer treatments.
It works by targeting a protein called Trop-2, which is found in high amounts on many cancer cells. After attaching to the cancer cell, Trodelvy enters the cell and releases SN-38, a medicine that damages the cancer cell and helps stop its growth.
Trodelvy 180mg Injection is given as an intravenous (IV) infusion by a healthcare professional at a hospital or cancer treatment centre.
Uses of Trodelvy 180mg Injection
Trodelvy 180mg Injection is used to treat:
- Triple-negative breast cancer (TNBC): Used in adults with unresectable locally advanced or metastatic TNBC who have received two or more previous systemic cancer treatments.
- HR-positive, HER2-negative breast cancer: Used in adults with metastatic breast cancer after endocrine-based treatment and at least two other systemic therapies.
- Urothelial cancer: Used in adults with locally advanced or metastatic urothelial cancer who have previously received platinum-based chemotherapy and a PD-1 or PD-L1 inhibitor.
The exact treatment and duration will be decided by your doctor based on your condition and previous treatments.
Storage
- Store Trodelvy vials in a refrigerator at 2°C to 8°C.
- Do not freeze the medicine.
- Keep the vial in its original carton to protect it from light.
- After preparation, the diluted medicine should be used within the time recommended by the healthcare professional and product instructions.
- Keep Trodelvy out of the reach of children.
Safety Advice
Pregnancy
Consult Your Doctor
Trodelvy may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for at least 6 months after the last dose.
Tell your doctor if you are pregnant, planning to become pregnant, or think you may be pregnant.
Breastfeeding
Consult Your Doctor
Do not breastfeed while receiving Trodelvy and for at least 1 month after the last dose. Talk to your doctor about safe feeding options during this period.
Lungs
Consult Your Doctor
Tell your doctor immediately if you develop a new or worsening cough, difficulty breathing, shortness of breath, or chest pain during treatment. These symptoms may require prompt medical attention.
Liver
Consult Your Doctor
Tell your doctor if you have liver problems. Trodelvy may increase exposure to its active drug component in patients with liver impairment and may increase the risk of side effects. Your doctor may monitor your liver function during treatment.
Alcohol
Consult Your Doctor
Talk to your doctor before consuming alcohol during treatment. Alcohol may worsen symptoms such as nausea, tiredness, or dizziness.
Driving
Consult Your Doctor
Trodelvy may cause tiredness, dizziness, or nausea in some people. Avoid driving or operating machinery if you experience these effects or if you do not feel alert.
FAQ
What is Trodelvy 180mg Injection used for?
Trodelvy 180mg Injection is used to treat certain types of cancer in adults. It may be prescribed for triple-negative breast cancer (TNBC), HR-positive/HER2-negative breast cancer, and urothelial cancer that has spread or cannot be treated with surgery. It is generally used after previous cancer treatments.
How does Trodelvy 180mg Injection work?
Trodelvy contains sacituzumab govitecan, an antibody-drug conjugate (ADC). It targets a protein called Trop-2 found on many cancer cells and delivers the chemotherapy medicine SN-38 into these cells. SN-38 damages the DNA of cancer cells and helps stop them from growing and causes them to die.
- Trodelvy is a prescription anticancer medicine containing sacituzumab govitecan, used by specialists for certain types of cancer. If you are researching trodelvy price, contact YourMediKart to confirm current pricing and product availability.
- Customers comparing trodelvy cost can request updated information and check applicable supply requirements. Learn more about the medicine by exploring sacituzumab govitecan price information and product details.
- If you are searching for sacituzumab govitecan price in india, verify current costs with a reliable supplier. Explore information about trodelvy in india, including product availability and prescription requirements.
- The trodelvy injection should be administer by qualified healthcare professionals according to the prescribe treatment schedule. For updated trodelvy price in india details, contact YourMediKart directly.
- Customers searching for trodelvy fiyat can also review the product listing for relevant information. Learn more about the trodelvy 180 mg presentation and confirm the exact formulation with the supplier. For further information about the trodelvy 180 mg vial, visit the product page and consult your oncologist regarding treatment suitability, administration, and safety precautions.
What is Trop-2?
Trop-2 (trophoblast cell-surface antigen 2) is a protein find on the surface of many cancer cells, including breast and urothelial cancer cells. Trodelvy targets this protein to help deliver its cancer-fighting medicine to the cancer cells.
How is Trodelvy 180mg Injection administer?
Trodelvy 180mg Injection is give through an intravenous (IV) infusion by a healthcare professional. The first infusion usually takes about 3 hours. If it is well tolerate, later infusions may take about 1 to 2 hours. Trodelvy is usually give on Day 1 and Day 8 of a 21-day treatment cycle, as prescribed by the doctor.
What are the common side effects of Trodelvy?
Common side effects of Trodelvy may include low white blood cell counts (neutropenia), nausea, diarrhea, tiredness, anemia, vomiting, hair loss, and abdominal pain. Low white blood cell counts and diarrhea are important side effects that may require medical monitoring and treatment.




Reviews
There are no reviews yet.